At the cytoskeletal level, the ER was reported regulates the K19 gene and localizes the estrogen-responsive region, implying that estrogen-induced keratin 19 gene expression may contribute to cytoskeletal and nuclear matrix reorganization and increased metastatic potential in ER-containing breast cancer cells [261]. This evidence concerns the gene KRT19 and breast carcinoma.